VIDEO: ‘Dietary interventions,’ behavioral therapy pivotal to address rising tide of IBS
Click Here to Manage Email Alerts
In a Healio video exclusive, Edward V. Loftus Jr., MD, urged gastroenterologists to prioritize identifying food triggers and recommending dietary interventions and behavioral therapy for patients with irritable bowel syndrome.
The United States has seen a rise in the prevalence of Rome IV irritable bowel syndrome — including its three subtypes, IBS with constipation (IBS-C), IBS with diarrhea (IBS-D) and IBS with mixed bowel habits (IBS-M) — with estimates climbing as high as 6.1% in 2023, surpassing previous reports of 4.7% to 5.3%.
Globally, the International Foundation for Gastrointestinal Disorders approximates that IBS affects 10% to 15% of the population, making it the most prevalent disorder of gut-brain interaction.
“The cover story in this month’s issue of Healio Gastroenterology [discusses] treatment of irritable bowel syndrome,” Loftus, the Maxine and Jack Zarrow Family Professor of Gastroenterology at the Mayo Clinic, told Healio. “This is really a great article, which involves three experts – Ling Chang, MD, William D. Chey, MD, and Anthony Lembo, MD, who provide a nice summary of how to approach the three different types of IBS and summarizes the AGA clinical guidelines, going through first-line, second-line and third-line therapies for each type.”
Loftus emphasized that GIs should be conveying to their patients “the importance of identifying food triggers, dietary interventions such as the low FODMAP diet and behavioral therapy because as you recall, these are disorders of gut-brain interaction.”
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts